$LUCD
Lucid Diagnostics Inc.

2023 Q1 Form 10-K Financial Statement

#000149315223007482 Filed on March 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $446.0K $112.0K $377.0K
YoY Change 135.98% -62.67% -24.6%
Cost Of Revenue $1.338M $1.618M $100.0M
YoY Change 262.6% 267.12% 16994.02%
Gross Profit -$892.0K -$1.506M $377.0K
YoY Change 395.56% 970.13% -543.53%
Gross Profit Margin -200.0% -1344.64% 100.0%
Selling, General & Admin $10.64M $10.48M $39.82M
YoY Change 15.52% 37.5% 120.8%
% of Gross Profit 10562.07%
Research & Development $2.282M $2.442M $11.47M
YoY Change -20.79% -29.86% 23.34%
% of Gross Profit 3041.38%
Depreciation & Amortization $612.0K $615.0K $1.936M
YoY Change 2450.0% 109721.43% 48300.0%
% of Gross Profit 513.53%
Operating Expenses $14.76M $13.42M $56.55M
YoY Change 22.11% 20.92% 106.88%
Operating Profit -$14.32M -$14.93M -$56.17M
YoY Change 16.68% 32.81% 104.86%
Interest Expense $33.00K $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$1.930M
YoY Change -193100.0%
Pretax Income -$16.25M -$14.93M -$56.17M
YoY Change 32.41% 32.04% 100.05%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$16.25M -$14.93M -$56.17M
YoY Change 32.41% 32.04% 100.05%
Net Earnings / Revenue -3642.83% -13328.57% -14899.47%
Basic Earnings Per Share -$0.40 -$1.55
Diluted Earnings Per Share -$0.40 -$0.40 -$1.55
COMMON SHARES
Basic Shares Outstanding 43.39M shares 39.11M shares 36.17M shares
Diluted Shares Outstanding 40.97M shares 36.17M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.52M $22.47M $22.47M
YoY Change -17.52% -58.11% -58.11%
Cash & Equivalents $39.52M $22.47M
Short-Term Investments
Other Short-Term Assets $2.172M $1.865M $1.865M
YoY Change -49.77% -45.89% -45.89%
Inventory $111.0K
Prepaid Expenses
Receivables $27.00K $17.00K $17.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $41.72M $24.36M $24.36M
YoY Change -20.28% -57.5% -57.5%
LONG-TERM ASSETS
Property, Plant & Equipment $1.502M $1.592M $3.600M
YoY Change -54.75% 63.95% 270.75%
Goodwill
YoY Change
Intangibles $2.940M $3.445M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.078M $1.108M $1.108M
YoY Change 55.11% 52.83% 52.83%
Total Long-Term Assets $7.404M $8.153M $8.153M
YoY Change -23.89% 380.72% 380.72%
TOTAL ASSETS
Total Short-Term Assets $41.72M $24.36M $24.36M
Total Long-Term Assets $7.404M $8.153M $8.153M
Total Assets $49.13M $32.51M $32.51M
YoY Change -20.84% -44.9% -44.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $625.0K $1.056M $1.056M
YoY Change -85.99% -29.13% -29.13%
Accrued Expenses $3.241M $1.851M $1.851M
YoY Change 8.21% 218.04% 218.04%
Deferred Revenue
YoY Change
Short-Term Debt $19.53M $4.960M $4.960M
YoY Change 1003.22% 199.34% 199.34%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.39M $8.425M $8.425M
YoY Change 65.74% 97.77% 97.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $826.0K $1.037M $1.037M
YoY Change -43.23%
Total Long-Term Liabilities $826.0K $1.037M $1.037M
YoY Change -43.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.39M $8.425M $8.425M
Total Long-Term Liabilities $826.0K $1.037M $1.037M
Total Liabilities $24.22M $9.462M $9.462M
YoY Change 55.56% 122.11% 122.11%
SHAREHOLDERS EQUITY
Retained Earnings -$114.3M -$98.08M
YoY Change 134.05%
Common Stock $42.00K $41.00K
YoY Change 17.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.91M $23.05M $23.05M
YoY Change
Total Liabilities & Shareholders Equity $49.13M $32.51M $32.51M
YoY Change -20.84% -44.9% -44.9%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$16.25M -$14.93M -$56.17M
YoY Change 32.41% 32.04% 100.05%
Depreciation, Depletion And Amortization $612.0K $615.0K $1.936M
YoY Change 2450.0% 109721.43% 48300.0%
Cash From Operating Activities -$7.045M -$4.258M -$29.69M
YoY Change 21.97% -56.89% 68.02%
INVESTING ACTIVITIES
Capital Expenditures $17.00K $203.0K $3.200M
YoY Change -111.49% -124.63% -471.23%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$3.200M
YoY Change
Cash From Investing Activities -$17.00K -$203.0K -$4.108M
YoY Change -88.51% -75.37% 376.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.807M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $24.11M 1.000K $2.611M
YoY Change 12793.05% -100.0% -96.38%
NET CHANGE
Cash From Operating Activities -$7.045M -4.258M -$29.69M
Cash From Investing Activities -$17.00K -203.0K -$4.108M
Cash From Financing Activities $24.11M 1.000K $2.611M
Net Change In Cash $17.05M -4.460M -$31.18M
YoY Change -397.16% -108.32% -158.24%
FREE CASH FLOW
Cash From Operating Activities -$7.045M -$4.258M -$29.69M
Capital Expenditures $17.00K $203.0K $3.200M
Free Cash Flow -$7.062M -$4.461M -$32.89M
YoY Change 25.48% -50.72% 95.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001799011
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 LUCD Issuance Of Common Stock Installment Settlement Payment
IssuanceOfCommonStockInstallmentSettlementPayment
usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2021 LUCD Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2021 LUCD Unsecured Debt Issued
UnsecuredDebtIssued
usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
usd
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2021Q4 LUCD Deferred Tax Assets Tax Deferred Expense Depreciation Amortization
DeferredTaxAssetsTaxDeferredExpenseDepreciationAmortization
usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40901
CY2022 dei Entity Registrant Name
EntityRegistrantName
LUCID DIAGNOSTICS INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5488042
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
360 Madison Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
25th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2022 dei City Area Code
CityAreaCode
(212)
CY2022 dei Local Phone Number
LocalPhoneNumber
949-4319
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2022 dei Trading Symbol
TradingSymbol
LUCD
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
18900000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43393716 shares
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22474000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53656000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
200000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1865000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3447000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
24356000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
57303000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1592000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
971000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2008000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3445000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1108000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
725000 usd
CY2022Q4 us-gaap Assets
Assets
32509000 usd
CY2021Q4 us-gaap Assets
Assets
58999000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1056000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1490000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1447000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1113000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
962000 usd
CY2022Q4 LUCD Msa Fee Operating Expenses And Interest Expense
MSAFeeOperatingExpensesAndInterestExpense
4960000 usd
CY2021Q4 LUCD Msa Fee Operating Expenses And Interest Expense
MSAFeeOperatingExpensesAndInterestExpense
1657000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8425000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4260000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1037000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9462000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4260000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40518792 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40518792 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34917907 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34917907 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
41000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
35000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
121081000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96608000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98075000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41904000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23047000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54739000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32509000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58999000 usd
CY2022 us-gaap Gross Profit
GrossProfit
377000 usd
CY2021 us-gaap Gross Profit
GrossProfit
500000 usd
CY2022 LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
3614000 usd
CY2021 LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
585000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16134000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5260000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23685000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12778000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1649000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11466000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9296000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
56548000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
27919000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-56171000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-27419000 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
659000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-659000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56171000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28078000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-56171000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28078000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36172421 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18603619 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-13518000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
22400000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64336000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9134000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
465000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28078000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54739000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
695000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13859000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1132000 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
211000 usd
CY2022 LUCD Stock Issued During Period Value Asset Acquisitions Installment Payments
StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPayments
653000 usd
CY2022 LUCD Issuance Committed Equity Facility Net Of Deferred Financing Charges
IssuanceCommittedEquityFacilityNetOfDeferredFinancingCharges
1767000 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
109000 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
6475000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-56171000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23047000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-56171000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28078000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1936000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
13859000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
9134000 usd
CY2022 LUCD Share Based Compensation Of Parent
ShareBasedCompensationOfParent
1132000 usd
CY2021 LUCD Share Based Compensation Of Parent
ShareBasedCompensationOfParent
465000 usd
CY2022 LUCD Issuance Of Common Stock Installment Settlement Payment
IssuanceOfCommonStockInstallmentSettlementPayment
653000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-183000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
200000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1163000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2088000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-445000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-665000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
333000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
926000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-223000 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7672000 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3057000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29685000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17668000 usd
CY2022 LUCD Payments Of Purchase Of Equipment
PaymentsOfPurchaseOfEquipment
908000 usd
CY2021 LUCD Payments Of Purchase Of Equipment
PaymentsOfPurchaseOfEquipment
862000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3200000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4108000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-862000 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
70000000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1807000 usd
CY2021 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
5664000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
695000 usd
CY2022 LUCD Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
109000 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7739000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2611000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
72075000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31182000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53545000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53656000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
111000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22474000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53656000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zTu6Dd6ZtR6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zEEpUv8fJHT1">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent losses, as of the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates in these consolidated financial statements include those related to the estimated fair value of stock-based equity awards and intangible assets. Other significant estimates include the estimated incremental borrowing rate, the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets. Additionally, management’s assessment of the Company’s ability to continue as a going concern involves the estimation of the amount and timing of future cash inflows and outflows. On an ongoing basis, the Company evaluates its estimates and assumptions. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 LUCD Common Stock Issued For Payroll And Benefit Expense Reimbursement Value
CommonStockIssuedForPayrollAndBenefitExpenseReimbursementValue
2719000 usd
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.00
CY2022 LUCD On Behalf Of Obo Activities
OnBehalfOfOboActivities
1263000 usd
CY2022 LUCD Erc Payroll Benefits
ErcPayrollBenefits
10204000 usd
CY2022 LUCD Cap Nostics Transfer
CapNosticsTransfer
2105000 usd
CY2022 LUCD Cash Payments
CashPayments
-9434000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zfXnlDyNkyVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassifications</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior-year amounts have been reclassified to conform to the current year presentation, which includes presenting costs of revenue within operating expenses on the statements of operations, in the consolidated financial statements and accompanying notes to the consolidated financial statements. The impact of the reclassifications made to prior year amounts is not material and did not affect net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Related Party Costs
RelatedPartyCosts
6475000 usd
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
4960000 usd
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
2100000 usd
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
2100000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500000 usd
CY2022 LUCD Cost Of Revenue Related To Laboratory Operations And Distributions
CostOfRevenueRelatedToLaboratoryOperationsAndDistributions
3614000 usd
CY2022 LUCD Expense Payment Milestone
ExpensePaymentMilestone
200000 usd
CY2022 us-gaap Royalty Expense
RoyaltyExpense
23000 usd
CY2021 us-gaap Royalty Expense
RoyaltyExpense
25000 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1649000 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1338000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21000 usd
CY2020Q4 us-gaap Due From Related Parties
DueFromRelatedParties
13261000 usd
CY2021 LUCD Msa Fees
MsaFees
3630000 usd
CY2021 LUCD On Behalf Of Obo Activities
OnBehalfOfOboActivities
8723000 usd
CY2021 LUCD Erc Payroll Benefits
ErcPayrollBenefits
1037000 usd
CY2021 LUCD Conversion Of Promissory Note Common Stock
ConversionOfPromissoryNoteCommonStock
-22400000 usd
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
659000 usd
CY2021 LUCD Cash Payments
CashPayments
-3253000 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
1657000 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
1657000 usd
CY2022 LUCD Msa Fees
MsaFees
5640000 usd
CY2022Q4 LUCD Common Stock Shares Issued For Payroll And Benefit Expense Reimbursement
CommonStockSharesIssuedForPayrollAndBenefitExpenseReimbursement
1479326 shares
CY2022 LUCD Royalty Percentage
RoyaltyPercentage
0.05 pure
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100000000 usd
CY2022 LUCD Royalty Percentage On Annual Sales
RoyaltyPercentageOnAnnualSales
0.080 pure
CY2022 LUCD Cost Of Goods And Services Sold Annually
CostOfGoodsAndServicesSoldAnnually
100000000 usd
CY2022Q4 LUCD Prepaid Service Providers And Suppliers
PrepaidServiceProvidersAndSuppliers
371000 usd
CY2021Q4 LUCD Prepaid Service Providers And Suppliers
PrepaidServiceProvidersAndSuppliers
260000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
52000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1578000 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
1331000 usd
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
1116000 usd
CY2022Q4 LUCD Esocheck Cell Collection Prepaid Supplies
EsocheckCellCollectionPrepaidSupplies
59000 usd
CY2021Q4 LUCD Esocheck Cell Collection Prepaid Supplies
EsocheckCellCollectionPrepaidSupplies
434000 usd
CY2022Q4 LUCD Esoguard Mailer Prepaid Supplies
EsoguardMailerPrepaidSupplies
52000 usd
CY2021Q4 LUCD Esoguard Mailer Prepaid Supplies
EsoguardMailerPrepaidSupplies
59000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1865000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3447000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1881000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
975000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
289000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1592000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
971000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
951000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
95000 usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
32000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
20000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1066000 usd
CY2021 us-gaap Lease Cost
LeaseCost
32000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1078000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1019000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
60000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2157000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
158000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1999000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
949000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2763000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07875 pure
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2008000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1999000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
962000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1037000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5305000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-1860000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3445000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1649000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2021000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
688000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
421000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
315000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3445000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
879000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
557000 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
10000 usd
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
25000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
558000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
531000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1447000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1113000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14991000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9599000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.71 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013 pure
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40518792 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34917907 shares
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1807000 usd
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
1000000.0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-12703000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4862000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1209000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4833000 usd
CY2022 LUCD Current And Deferred Income Tax Expense Benefit
CurrentAndDeferredIncomeTaxExpenseBenefit
-11494000 usd
CY2021 LUCD Current And Deferred Income Tax Expense Benefit
CurrentAndDeferredIncomeTaxExpenseBenefit
-9695000 usd
CY2022 LUCD Valuation Allowance Reserve
ValuationAllowanceReserve
-11494000 usd
CY2021 LUCD Valuation Allowance Reserve
ValuationAllowanceReserve
-9695000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.072 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.136 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.006 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.005 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.088 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.205 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.346 pure
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16015000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11023000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6920000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3422000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
80000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
56000 usd
CY2022Q4 LUCD Deferred Tax Assets Tax Deferred Expense Depreciation Amortization
DeferredTaxAssetsTaxDeferredExpenseDepreciationAmortization
240000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2442000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
295000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25992000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14501000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
3000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
25992000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
14498000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25992000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14498000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
65100000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
31900000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
65100000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
31900000 usd
CY2022 LUCD Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
expiration dates commencing in 2037
CY2022Q3 LUCD Effective Income Tax Rate Continuing Operations Description
EffectiveIncomeTaxRateContinuingOperationsDescription
the U.S. Congress passed the Inflation Reduction Act, which included a corporate minimum tax on book earnings of 15%, an excise tax on corporate share repurchases of 1%, and certain climate change and energy tax credit incentives. The adoption of a corporate minimum tax of 15% is not expected to impact Lucid’s effective tax rate. The excise tax of 1% on corporate share buybacks will not have an impact on the Company’s effective tax rate.
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-56171000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28078000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36172421 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18603619 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4656797 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3359982 shares

Files In Submission

Name View Source Status
0001493152-23-007482-index-headers.html Edgar Link pending
0001493152-23-007482-index.html Edgar Link pending
0001493152-23-007482.txt Edgar Link pending
0001493152-23-007482-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lucd-20221231_cal.xml Edgar Link unprocessable
ex10-16.htm Edgar Link pending
ex10-18.htm Edgar Link pending
ex10-4_6.htm Edgar Link pending
ex10-5.htm Edgar Link pending
ex10-9.htm Edgar Link pending
ex14-1.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
lucd-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
lucd-20221231_def.xml Edgar Link unprocessable
lucd-20221231_lab.xml Edgar Link unprocessable
lucd-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending